Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Silo Pharma (SILO) Gross Profit (2019 - 2025)

Silo Pharma's Gross Profit history spans 7 years, with the latest figure at -$2662.0 for Q3 2025.

  • For Q3 2025, Gross Profit fell 116.07% year-over-year to -$2662.0; the TTM value through Sep 2025 reached $47036.0, down 29.02%, while the annual FY2024 figure was $66264.0, 0.0% changed from the prior year.
  • Gross Profit for Q3 2025 was -$2662.0 at Silo Pharma, down from $16566.0 in the prior quarter.
  • Across five years, Gross Profit topped out at $29589.0 in Q2 2021 and bottomed at -$2662.0 in Q3 2025.
  • The 5-year median for Gross Profit is $16566.0 (2021), against an average of $16239.3.
  • The largest annual shift saw Gross Profit surged 7787.14% in 2021 before it tumbled 116.07% in 2025.
  • A 5-year view of Gross Profit shows it stood at $16566.0 in 2021, then changed by 0.0% to $16566.0 in 2022, then changed by 0.0% to $16566.0 in 2023, then changed by 0.0% to $16566.0 in 2024, then crashed by 116.07% to -$2662.0 in 2025.
  • Per Business Quant, the three most recent readings for SILO's Gross Profit are -$2662.0 (Q3 2025), $16566.0 (Q2 2025), and $16566.0 (Q1 2025).